The Relationship Between Probiotic Intake and Glycemic Profiles Among Metformin-Treated Type 2 Diabetes Patients

Rahma Ayu Larasati; Silviah; Farabillah Afifah; Siti Hadzul Aniyah

doi:10.24036/eksakta/vol27-iss01/648

EKSAKTA: Berkala Ilmiah Bidang MIPA

Open Access

The Relationship Between Probiotic Intake and Glycemic Profiles Among Metformin-Treated Type 2 Diabetes Patients

Rahma Ayu Larasati ¹

, Silviah ²

, Farabillah Afifah ¹

, Siti Hadzul Aniyah ²

¹ Department of Biomedicines, Faculty of Medicines and Health, Universitas Muhammadiyah Jakarta, Indonesia

² Medical student, Faculty of Medicines and Health, Universitas Muhammadiyah Jakarta, Indonesia

Published 2026-02-28

Vol. 27 No. 01 (2026) PAGES 93-100

DOI 10.24036/eksakta/vol27-iss01/648

Views / Downloads 64 46

Download PDF

Abstract

The ideal management of Type 2 Diabetes Mellitus should evolve from mere glucose-lowering strategies to a more comprehensive framework encompassing personalized medicine, technological integration, and systemic organ protection. A significant number of patients with Diabetes Mellitus (DM) continue to suffer from mortality and serious complications despite being on pharmacological therapy. Although trillions of dollars are spent annually on its management, diabetes remains a leading cause of mortality, claiming millions of lives each year across the globe. Probiotics have been proposed as an adjunctive therapy due to their role in modulating gut microbiota and glucose metabolism. This study aimed to analyze the effect of probiotic supplementation on Fasting Blood Sugar (FBS) levels in T2DM patients receiving metformin monotherapy. This experimental study involved 32 respondents, divided into probiotic intervention and placebo groups. FBS levels were measured pre- and post-intervention. Statistical analysis using the Paired T-Test showed a significant reduction in FBS levels (p=0.019). Conclusion: Probiotic supplementation significantly reduced FBS levels in T2DM patients on metformin monotherapy. However, this reduction was not clinically significant, as the final FBS levels did not differ significantly between the probiotic and placebo groups.

References

1

[1] Purnamasari D. (2014). Buku Ajar Ilmu Penyakit Dalam. VI. Vol. 2. Interna Publishing.

2

[2] International Diabetes Federation. https://idf.org/about-diabetes/diabetes-facts-figures/. 2025. Diabetes Facts and Figures.

3

[3] Dinas Kesehatan Provinsi NTB. Cakupan Pelayanan Kesehatan Penderita Diabetes Melitus Provinsi NTB. https://data.ntbprov.go.id/dataset/pelayanan-kesehatan-penderita-diabetes-melitus-dm-di-provinsi-ntb/resource/bdba586e-5698 2023

4

[4] Abhilash, P., Dsouza, D. J., Sradha, S., Nandakumar, U. P., Ahmed, S., Kolar, R., & Chand, S. (2023). Factors influencing adherence towards oral hypoglycaemic agents-A cross-sectional study among patients with Type II Diabetes Mellitus. Diabetes Epidemiology and Management, 12, 100163.

5

[5] Elmuzghi, R. F. (2023). Assessing the influential factors associated with medication non-adherence and self-care practices among type 2 diabetes mellitus patients in Tripoli, Libya. Sciences of Pharmacy, 2(2), 104-116.

6

[6] Indonesia, P. E. (2015). Pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Pb. Perkeni, 6.

7

[7] Dewvi, P. A. S., Aryaweda, M. D. W., Mahayana, N. P. K., Devi, N. P., Yadmika, N. P. W. P., & Sumartini, N. K. (2025). The effects of probiotic or synbiotic supplementation on glycemic control and lipid profile for type 2 diabetic patients. Intisari Sains Medis, 16(2), 695-701.

8

[8] Ayesha, I. E., Monson, N. R., Klair, N., Patel, U., Saxena, A., Patel, D., ... & Ayesha, I. E. (2023). Probiotics and their role in the management of type 2 diabetes mellitus (Short-term versus long-term effect): A systematic review and meta-analysis. Cureus, 15(10).

9

[9] AkbariRad, M., Shariatmaghani, S. S., Razavi, B. M., Majd, H. M., Shakhsemampour, Z., Sarabi, M., ... & Khorasani, Z. M. (2023). Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study. Diabetology & Metabolic Syndrome, 15(1), 71.

10

[10] FAO, W. (2006). Probiotics in food: Health and nutritional properties and guidelines for evaluation. 2006. FAO Food and Nutritional Paper, 85.

11

[11] Latif, A., Shehzad, A., Niazi, S., Zahid, A., Ashraf, W., Iqbal, M. W., ... & Korma, S. A. (2023). Probiotics: mechanism of action, health benefits and their application in food industries. Frontiers in microbiology, 14, 1216674.

12

[12] He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., ... & Zhu, L. (2020). Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. International journal of molecular sciences, 21(17), 6356.

13

[13] Rittiphairoj, T., Pongpirul, K., Janchot, K., Mueller, N. T., & Li, T. (2021). Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Advances in nutrition, 12(3), 722-734.

14

[14] Vallejos, O. P., Bueno, S. M., & Kalergis, A. M. (2025). Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects. Trends in molecular medicine, 31(8), 731-742.

15

[15] Samsudin, D. D., Firmansyah, A., Hidayati, E. L., Yuniar, I., Karyanti, M. R., & Roeslani, R. D. (2020). Effects of probiotic on gut microbiota in children with acute diarrhea: a pilot study. Paediatrica Indonesiana, 60(2), 83-90.

16

[16] Mafi, A., Namazi, G., Soleimani, A., Bahmani, F., Aghadavod, E., & Asemi, Z. (2018). Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Food & function, 9(9), 4763-4770.

17

[17] Madempudi, R. S., Ahire, J. J., Neelamraju, J., Tripathi, A., & Nanal, S. (2019). Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: a double blind, randomized, placebo controlled study. PloS one, 14(11), e0225168.

18

[18] BPOM (OTSKK). (2024). Daftar Strain Probiotik yang telah diizinkan. https://standar-otskk.pom.go.id/otskk-db/kategori/daftar-strain-probiotik-yang-telah-diizinkan.

19

[19] MIMS. https://www.mims.com/indonesia/drug/info/l-bio?type=brief&lang=id. 2026. L - Bio.

20

[20] Speich, B., Logullo, P., Deuster, S., Marian, I. R., Moschandreas, J., Heravi, A. T., ... & MAking Randomized Trials Affordable (MARTA) Group. (2021). A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials. Journal of clinical epidemiology, 131, 70-78.

21

[21] Wulandari, L. S., Kusumastuty, I., Cempaka, A. R., & Nugroho, F. A. (2023). Effect of Buffalo Curd Milk-Edamame Pudding Snack Consumption on Fasting Blood Glucose Levels and Lipid Profile in Diabetes Mellitus Patients. Amerta Nutrition, 7(4).

22

[22] Fusco, W., Lorenzo, M. B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., ... & Ianiro, G. (2023). Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients, 15(9), 2211.

23

[23] Viana, M. D. M., Santos, S. S., Cruz, A. B. O., de Jesus, M. V. A. C., Lauria, P. S. S., Lins, M. P., & Villarreal, C. F. (2025). Probiotics as antioxidant strategy for managing diabetes mellitus and its complications. Antioxidants, 14(7), 767.

24

[24] Watt, R., Parkin, K., & Martino, D. (2020). The potential effects of short-chain fatty acids on the epigenetic regulation of innate immune memory. Challenges, 11(2), 25.

25

[25] Feng, C., Jin, C., Liu, K., & Yang, Z. (2023). Microbiota-derived short chain fatty acids: Their role and mechanisms in viral infections. Biomedicine & Pharmacotherapy, 160, 114414.

26

[26] Zheng, J., An, Y., Du, Y., Song, Y., Zhao, Q., & Lu, Y. (2024). Effects of short-chain fatty acids on blood glucose and lipid levels in mouse models of diabetes mellitus: A systematic review and network meta-analysis. Pharmacological Research, 199, 107041.

27

[27] Pham, N. H., Joglekar, M. V., Wong, W. K., Nassif, N. T., Simpson, A. M., & Hardikar, A. A. (2024). Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis. Nutrition Reviews, 82(2), 193-209.

28

[28] Hulston, C. J., Churnside, A. A., & Venables, M. C. (2015). Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. British Journal of Nutrition, 113(4), 596-602.

29

[29] Rezazadeh, L., Alipour, B., Jafarabadi, M. A., Behrooz, M., & Gargari, B. P. (2021). Daily consumption effects of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 on oxidative stress in metabolic syndrome patients. Clinical nutrition ESPEN, 41, 136-142.

30

[30] Hsieh, M. C., Tsai, W. H., Jheng, Y. P., Su, S. L., Wang, S. Y., Lin, C. C., ... & Chang, W. W. (2018). The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Scientific reports, 8(1), 16791.

The Relationship Between Probiotic Intake and Glycemic Profiles Among Metformin-Treated Type 2 Diabetes Patients

Abstract

References

How to Cite

Most read articles by the same author(s)

The Relationship Between Probiotic Intake and Glycemic Profiles Among Metformin-Treated Type 2 Diabetes Patients

Abstract

References

How to Cite

Cite Article

Article Update

Most read articles by the same author(s)